| Typicality: | 0.377 |
| Saliency: | 0.297 |
| during tafenoquine consultation forums | 3 | temporal |
| around personal safety | 2 | other |
| initiative → address → concern | 10 |
| initiative → respond to → concern | 3 |
| negative | neutral | positive |
| 0.024 | 0.586 | 0.390 |
| Raw frequency | 13 |
| Normalized frequency | 0.297 |
| Modifier score | 0.500 |
| Perplexity | 90.283 |